Gainers & Losers
Tue Dec 09 2025 09:55:52- Eternal share price
- ₹291.852.31%
- Titan Company share price
- ₹3,846.702.17%
- Adani Ports and Special Ec...
- ₹1,495.701.07%
- Bharat Electronics share price
- ₹389.950.89%
- State Bank of India share price
- ₹960.050.41%
Active Stocks
Tue Dec 09 2025 10:28:53- Suzlon Energy share price
- ₹52.571.51%
- Yes Bank share price
- ₹22.020.64%
- Federal Bank share price
- ₹260.951.38%
- Adani Power share price
- ₹142.002.12%
- Canara Bank share price
- ₹146.052.24%
Business News/Market/Market Stats/Sun Pharmaceutical Industries share price/ Sun Pharmaceutical Industries Profit Loss Annual
Sun Pharmaceutical Industries Profit & Loss Annual
1,776.45 -18.85 (-1.05%)Updated : 09 Dec 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 40,674.51 | 38,479.92 | 34,793.33 | 35,076.82 |
| Other Net | 346.07 | -145.70 | 27.31 | 334.17 |
| Diluted Weighted Average Shares | 239.93 | 239.93 | 239.93 | 239.93 |
| Gain( Loss)on Saleof Assets | 5.35 | -9.97 | 7.54 | 34.75 |
| Depreciation/ Amortization | 2,575.39 | 2,556.79 | 2,529.43 | 2,143.74 |
| Operating Income | 11,903.93 | 10,016.93 | 9,092.35 | 3,577.67 |
| Net Income | 10,929.04 | 9,576.38 | 8,473.58 | 3,272.73 |
| Income Availableto Com Excl Extra Ord | 10,929.04 | 9,576.38 | 8,473.58 | 3,272.73 |
| Other Operating Expenses Total | 1,154.98 | 1,189.04 | 738.24 | 709.74 |
| Net Income Before Taxes | 13,752.13 | 11,087.89 | 9,408.43 | 4,481.32 |
| Minority Interest | -35.71 | -33.65 | -39.36 | -116.55 |
| Net Income After Taxes | 10,980.10 | 9,648.44 | 8,560.84 | 3,405.82 |
| Income Availableto Com Incl Extra Ord | 10,929.04 | 9,576.38 | 8,473.58 | 3,272.73 |
| Costof Revenue Total | 12,197.51 | 12,069.66 | 11,942.42 | 11,707.65 |
| Gross Profit | 40,380.93 | 36,427.19 | 31,943.26 | 26,946.84 |
| Interest Inc( Exp) Net- Non- Op Total | 1,496.78 | 1,226.63 | 281.23 | 534.73 |
| Unusual Expense( Income) | 718.69 | 492.72 | 188.37 | 4,570.27 |
| Diluted Net Income | 10,929.04 | 9,576.38 | 8,473.58 | 3,272.73 |
| DPS- Common Stock Primary Issue | 16.00 | 13.50 | 11.50 | 10.00 |
| Provisionfor Income Taxes | 2,772.03 | 1,439.45 | 847.59 | 1,075.50 |
| Equity In Affiliates | -15.35 | -38.41 | -47.90 | -16.54 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 10,929.04 | 9,576.38 | 8,473.58 | 3,272.73 |
| Total Revenue | 52,578.44 | 48,496.85 | 43,885.68 | 38,654.49 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 52,578.44 | 48,496.85 | 43,885.68 | 38,654.49 |
| Selling/ General/ Admin Expenses Total | 24,027.94 | 22,171.71 | 19,394.87 | 15,945.42 |
| Diluted Normalized EPS | 47.92 | 41.74 | 36.01 | 28.03 |
| Diluted EPS Excluding Extra Ord Items | 45.55 | 39.91 | 35.32 | 13.64 |
*All figures in crores except per share values
Sun Pharmaceutical Industries Quick Links
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Cashflow Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
291.85+6.60(2.31%)
3,846.70+81.70(2.17%)
1,495.70+15.90(1.07%)
2,790.70-135.10 (-4.62%)
1,559.80-31.95 (-2.01%)